Skip to main content
. 2016 Feb 17;11(2):e0149183. doi: 10.1371/journal.pone.0149183

Table 1. Probes where high expression is prognostic of poor outcome with an FDR <0.05.

(25–75)% is the difference in expression of the 25th and 75th percentile expression on a log scale. The Stouffer p-value was used as the ranking metric combining the p-values from each cohort.

TCGA Ovarian Broad OS Stage 3 and 4 HAS Ovarian OS Stage 3 and 4(No TCGA)
REF Probe p-value HR 95% CI (25–75)% p-value HR 95% CI (25–75)% Stouffer FDR
AXL 202686_s_at 2.29E-04 1.27 CI(1.12–1.45) 1.3 0.001 1.29 CI(1.10–1.50) 0.7 1.83E-06 0.022
APC 203525_s_at 4.92E-05 1.33 CI(1.16–1.52) 0.8 0.017 1.22 CI(1.04–1.43) 0.7 5.01E-06 0.029
RAB11FIP5 210879_s_at 7.59E-05 1.29 CI(1.14–1.46) 0.7 0.039 1.19 CI(1.01–1.40) 0.4 1.82E-05 0.041
C19orf2 211563_s_at 0.007 1.19 CI(1.05–1.35) 1.1 1.85E-04 1.36 CI(1.16–1.60) 0.6 2.92E-05 0.041
CYBRD1 217889_s_at 3.91E-04 1.24 CI(1.10–1.40) 2 0.014 1.21 CI(1.04–1.41) 1.3 2.99E-05 0.041
PINK1 209019_s_at 0.006 1.19 CI(1.05–1.34) 0.7 4.83E-04 1.31 CI(1.12–1.52) 0.5 4.42E-05 0.041
LRRN3 209840_s_at 4.84E-05 1.21 CI(1.10–1.32) 0.3 0.118 1.13 CI(0.97–1.33) 1.8 4.78E-05 0.041
AQP1 207542_s_at 0.005 1.19 CI(1.05–1.35) 0.8 8.19E-04 1.33 CI(1.12–1.57) 0.7 5.02E-05 0.041
DES 214027_x_at 0.005 1.18 CI(1.05–1.32) 0.5 8.46E-04 1.29 CI(1.11–1.49) 1.3 5.13E-05 0.041
XRCC4 205072_s_at 0.053 1.13 CI(1.00–1.27) 0.6 3.62E-06 1.48 CI(1.26–1.75) 0.7 6.35E-05 0.047
BCHE 205433_at 4.09E-04 1.23 CI(1.10–1.37) 0.7 0.033 1.20 CI(1.01–1.43) 1.7 7.10E-05 0.048
ASAP3 219103_at 1.26E-04 1.27 CI(1.13–1.44) 0.6 0.088 1.14 CI(0.98–1.32) 0.9 7.34E-05 0.048